NeuBase Therapeutics, Inc. Common Stock
NBSE
NBSE was delisted on the 10th of May, 2024.
52 hedge funds and large institutions have $22.9M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 6 closing their positions.
139% more capital invested
Capital invested by funds: $9.59M → $22.9M (+$13.3M)
108% more call options, than puts
Call options by funds: $3.27M | Put options by funds: $1.57M
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
11% more funds holding
Funds holding: 47 → 52 (+5)
13% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$640K |
| 2 |
ARTA
A.R.T. Advisors
New York
|
+$533K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$293K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$223K |
| 5 |
Neuberger Berman Group
New York
|
+$177K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$450K |
| 2 |
Group One Trading
Chicago,
Illinois
|
-$232K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$200K |
| 4 |
FNBT
FineMark National Bank & Trust
Fort Myers,
Florida
|
-$115K |
| 5 |
Goldman Sachs
New York
|
-$105K |
NBSE Hedge Fund Activity: Q4 2015 in Review
52 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q4 2015, worth a combined $22.9M — up 139% from $9.59M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new NBSE positions and 6 closed out — a net gain of 5 holders — while 13 added to existing stakes and 15 trimmed.
The largest buyer was Deutsche Bank, adding an estimated $640K. The largest seller was Susquehanna International Group, cutting an estimated $450K.
- 52 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q4 2015, up from 47 in Q3 2015.
- Funds reported $22.9M of NeuBase Therapeutics, Inc. Common Stock stock for Q4 2015, up 139% quarter-over-quarter.
- 11 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q4 2015 and 6 closed out, a net change of +5 holders.
- The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q4 2015 was Deutsche Bank, an estimated $640K added.
- The largest NeuBase Therapeutics, Inc. Common Stock seller in Q4 2015 was Susquehanna International Group, an estimated $450K sold.
Based on aggregated 13F filings for Q4 2015.